{{Rsnum
|rsid=9288952
|Gene=BTLA
|Chromosome=3
|position=112466178
|Orientation=plus
|GMAF=0.3095
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=BTLA
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 92.9 | 7.1 | 0.0
| HCB | 59.9 | 34.3 | 5.8
| JPT | 49.6 | 46.0 | 4.4
| YRI | 0.7 | 18.4 | 81.0
| ASW | 14.0 | 45.6 | 40.4
| CHB | 59.9 | 34.3 | 5.8
| CHD | 41.3 | 47.7 | 11.0
| GIH | 70.3 | 26.7 | 3.0
| LWK | 3.6 | 20.0 | 76.4
| MEX | 41.4 | 41.4 | 17.2
| MKK | 13.5 | 39.4 | 47.1
| TSI | 89.2 | 9.8 | 1.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19585237
|Title=Association of BTLA gene polymorphisms with the risk of malignant breast cancer in Chinese women of Heilongjiang Province
}}

{{GET Evidence
|gene=BTLA
|aa_change=Pro267Leu
|aa_change_short=P267L
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs9288952
|overall_frequency_n=7820
|overall_frequency_d=10758
|overall_frequency=0.726901
|n_genomes=40
|n_genomes_annotated=0
|n_haplomes=65
|n_articles=0
|n_articles_annotated=0
|nblosum100=7
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}